Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.1 - $3.58 $4,900 - $15,948
-4,455 Reduced 28.59%
11,130 $19,000
Q4 2022

Feb 14, 2023

BUY
$0.94 - $3.28 $14,649 - $51,118
15,585 New
15,585 $19,000

Others Institutions Holding ARMP

About Armata Pharmaceuticals, Inc.


  • Ticker ARMP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,144,700
  • Market Cap $96.5M
  • Description
  • Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...
More about ARMP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.